Lamisil

Manufacturer: GlaxoSmithKline Consumer Healthcare Holdings (US) LLC
Effective date: 2021-06-15
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-01 22:43:27

Label at a glance#

ProductLamisil AT Jock Itch

Active ingredientTERBINAFINE HYDROCHLORIDE

Label structure13 sections

Indications and uses

• cures most jock itch (tinea cruris) and ringworm (tinea corporis) • relieves itching, burning, cracking and scaling which accompany these conditions

Dosage and administration

• adults and children 12 years and over: • use the tip of the cap to break the seal and open the tube • wash the affected skin with soap and water and dry completely before applying • apply once a day (morning or night) for 1 week or as directed by a doctor • wash hands after each use • children under 12 years: ask a doctor

Storage and handling

• do not use if seal on tube is broken or is not visible • store at controlled room temperature 20-25°C (68-77°F)

Contacts and useful links#

PhoneLabel contact1-800-330-9876

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Terbinafine hydrochloride 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

cures most jock itch (tinea cruris) and ringworm (tinea corporis)
relieves itching, burning, cracking and scaling which accompany these conditions

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

on nails or scalp
in or near the mouth or eyes
for vaginal yeast infections

When using this product

OTC - WHEN USING SECTION

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask doctor if

OTC - STOP USE SECTION

too much irritation occurs or gets worse

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a poison control center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and over:
- use the tip of the cap to break the seal and open the tube
- wash the affected skin with soap and water and dry completely before applying
- apply once a day (morning or night) for 1 week or as directed by a doctor
- wash hands after each use
children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

do not use if seal on tube is broken or is not visible
store at controlled room temperature 20-25°C (68-77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

Questions or comments?

OTC - QUESTIONS SECTION

call 1-800-330-9876

Distributed by: GSK Consumer Healthcare, Warren, NJ 07059

Trademarks owned or licensed by GSK.

13510 (Front Carton)

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 0067-3999-42

LAMISIL AT CREAM

gsk

TERBINAFINE HYDROCHLORIDE CREAM 1% - ANTIFUNGAL

FOR JOCK ITCH

NET WT 12 g (0.42 oz)

13510 (Front Carton)

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0067-3999-42	GM - Gram	0067-3999	e2c43041-7171-4b2d-bba5-9a1d2289416f	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
TERBINAFINE HYDROCHLORIDE	ACTIVE INGREDIENT	012C11ZU6G	1
TERBINAFINE	ACTIVE MOIETY	G7RIW8S0XP	1
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	1
CETYL ALCOHOL	INACTIVE INGREDIENT	936JST6JCN	1
CETYL PALMITATE	INACTIVE INGREDIENT	5ZA2S6B08X	1
ISOPROPYL MYRISTATE	INACTIVE INGREDIENT	0RE8K4LNJS	1
POLYSORBATE 60	INACTIVE INGREDIENT	CAL22UVI4M	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	1
SORBITAN MONOSTEARATE	INACTIVE INGREDIENT	NVZ4I0H58X	1
STEARYL ALCOHOL	INACTIVE INGREDIENT	2KR89I4H1Y	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

Lamisil AT Jock Itch
TERBINAFINE HYDROCHLORIDE
TERBINAFINE
BENZYL ALCOHOL
CETYL ALCOHOL
CETYL PALMITATE
ISOPROPYL MYRISTATE
POLYSORBATE 60
WATER
SODIUM HYDROXIDE
SORBITAN MONOSTEARATE
STEARYL ALCOHOL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0067-3999	0067-3999-42

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TERBINAFINE HYDROCHLORIDE	012C11ZU6G	ACTIB
BENZYL ALCOHOL	LKG8494WBH	IACT
CETYL ALCOHOL	936JST6JCN	IACT
CETYL PALMITATE	5ZA2S6B08X	IACT
ISOPROPYL MYRISTATE	0RE8K4LNJS	IACT
POLYSORBATE 60	CAL22UVI4M	IACT
WATER	059QF0KO0R	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
SORBITAN MONOSTEARATE	NVZ4I0H58X	IACT
STEARYL ALCOHOL	2KR89I4H1Y	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 302 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	OINTMENT / TOPICAL	2 %w/w		Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CAPSULE, LIQUID FILLED / ORAL	1.5 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GEL, METERED / TRANSDERMAL		350 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRA-ARTERIAL	0.9 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / PERIODONTAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUPPOSITORY / RECTAL	129 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTABLE, LIPOSOMAL / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, EMULSION / INTRAMUSCULAR		225 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CAPSULE / ORAL	60 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	OINTMENT, AUGMENTED / TOPICAL	0.11 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, FILM COATED / ORAL		8 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET / ORAL	1.06 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CAPSULE, DELAYED RELEASE / ORAL	0.25 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	DROPS / OPHTHALMIC	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	GEL / TRANSDERMAL		85 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	GEL, METERED / TRANSDERMAL		50 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	OIL / TOPICAL		213 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVENOUS		78 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SPRAY, METERED / NASAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	TABLET, COATED / ORAL	0.25 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SPRAY / NASAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAVESICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	LIQUID / TOPICAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	136.55 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
POLYSORBATE 60	POLYSORBATE 60	CAL22UVI4M	CREAM / TOPICAL		225 mg	Exact identifier — unii candidate 13 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRASPINAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / INTRAMUSCULAR		54 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAVITREAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	EMULSION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SORBITAN MONOSTEARATE	SORBITAN MONOSTEARATE	NVZ4I0H58X	SUSPENSION / ORAL	62.5 mg/5ml		Exact identifier — unii candidate 11 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CREAM, AUGMENTED / TOPICAL		6 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
STEARYL ALCOHOL	STEARYL ALCOHOL	2KR89I4H1Y	CAPSULE, EXTENDED RELEASE / ORAL	72 mg		Exact identifier — unii candidate 12 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTERSTITIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	AEROSOL, METERED / RESPIRATORY (INHALATION)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRATUMOR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / SUBMUCOSAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
STEARYL ALCOHOL	STEARYL ALCOHOL	2KR89I4H1Y	CREAM / VAGINAL		425 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, DELAYED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPERITONEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRAMUSCULAR		40 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
CETYL ALCOHOL	CETYL ALCOHOL	936JST6JCN	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	59 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRACAVITARY	0.01 ml		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INFILTRATION	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / AURICULAR (OTIC)	0.9 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS	NA		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / INTRAVASCULAR	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / DENTAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	GEL / VAGINAL		100 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAVENOUS		1620 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
CETYL PALMITATE	CETYL PALMITATE	5ZA2S6B08X	OINTMENT / TOPICAL	NA		Exact identifier — unii candidate 4 equally ranked IID candidates
ISOPROPYL MYRISTATE	ISOPROPYL MYRISTATE	0RE8K4LNJS	AEROSOL, SPRAY / TOPICAL	6.89 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020980-001	LAMISIL	TERBINAFINE HYDROCHLORIDE	1%	CREAM / TOPICAL		RLD, RS	1999-03-09

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N020980-001	LAMISIL	1%	CREAM / TOPICAL	RLD, RS	1999-03-09	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
a39c0cb8-dce2-401e-b52d-e1e7b65ab1fe			1757a9c4-e989-4f2d-bedc-0ba5137c68dc	2024-03-25	Warnings	Exact identifier spl set id: 1757a9c4-e989-4f2d-bedc-0ba5137c68dc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.